{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T22:09:16Z","timestamp":1783375756459,"version":"3.54.6"},"reference-count":82,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T00:00:00Z","timestamp":1700265600000},"content-version":"am","delay-in-days":352,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["L'Enc\u00e9phale"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.encep.2022.03.013","type":"journal-article","created":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T10:36:34Z","timestamp":1660818994000},"page":"700-711","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Prise en charge de l\u2019hypersialorrh\u00e9e iatrog\u00e8ne\u00a0: revue de la litt\u00e9rature et recommandations pratiques"],"prefix":"10.1016","volume":"48","author":[{"given":"E.","family":"Cuvelier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Gressier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Fovet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"D\u00e9caudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0799-8526","authenticated-orcid":false,"given":"A.","family":"Amad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.encep.2022.03.013_bib0415","doi-asserted-by":"crossref","first-page":"466","DOI":"10.2165\/00023210-199911060-00004","article-title":"Hypo- and hypersalivation induced by psychoactive drugs incidence, mechanisms and therapeutic implications","volume":"11","author":"Szabadi","year":"1999","journal-title":"CNS Drugs"},{"issue":"9","key":"10.1016\/j.encep.2022.03.013_bib0420","doi-asserted-by":"crossref","DOI":"10.1111\/joor.12664","article-title":"Salivary secretion in health and disease","volume":"45","author":"Pedersen","year":"2018","journal-title":"J Oral Rehabil"},{"issue":"3","key":"10.1016\/j.encep.2022.03.013_bib0425","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/JCP.0000000000001198","article-title":"Reporting patterns of sialorrhea comparing users of clozapine to users of other antipsychotics: A disproportionality analysis using vigibase","volume":"40","author":"Man","year":"2020","journal-title":"J Clin Psychopharmacol"},{"issue":"4","key":"10.1016\/j.encep.2022.03.013_bib0455","first-page":"758","article-title":"Hypersalivation induced by olanzapine with fluvoxamine","volume":"30","author":"Hori","year":"2006","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry. 2006\u00a0Jun;30(4):758-60. doi: 10.1016\/j.pnpbp.2006.01.018. Epub"},{"issue":"3","key":"10.1016\/j.encep.2022.03.013_bib0430","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00213-005-0248-4","article-title":"Clozapine-induced sialorrhea: pathophysiology and management strategies","volume":"185","author":"Praharaj","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.encep.2022.03.013_bib0440","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.psychres.2019.01.110","article-title":"Reasons for clozapine discontinuation in patients with treatment-resistant schizophrenia","volume":"275","author":"Ucok","year":"2019","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.encep.2022.03.013_bib0410","unstructured":"Les revues narratives: fondements scientifiques pour soutenir l\u2019\u00e9tablissement de rep\u00e8res institutionnels. Institut National de Sant\u00e9 Publique du Qu\u00e9bec, mai 2021. Available from: URL: https:\/\/www.inspq.qc.ca\/sites\/default\/files\/publications\/2780_revues_narratives_fondements_scientifiques_0.pdf."},{"key":"10.1016\/j.encep.2022.03.013_bib0445","unstructured":"Haute Autorit\u00e9 de Sant\u00e9, Etats des lieux. Niveau de preuve et gradation des recommandations de bonne pratique, avril 2013. Available from: URL: https:\/\/www.has-sante.fr\/upload\/docs\/application\/pdf\/2013-06\/etat_des_lieux_niveau_preuve_gradation.pdf."},{"issue":"11","key":"10.1016\/j.encep.2022.03.013_bib0450","first-page":"1174","article-title":"Hypersalivation and clozapine","volume":"42","author":"Bourgeois","year":"1991","journal-title":"Hosp Community Psychiatry"},{"issue":"1","key":"10.1016\/j.encep.2022.03.013_bib0475","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/WNF.0b013e3181634e8e","article-title":"Quetiapine-induced dose-dependent hypersalivation in mania","volume":"32","author":"Oulis","year":"2009","journal-title":"Clin Neuropharmacol"},{"issue":"1","key":"10.1016\/j.encep.2022.03.013_bib0470","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2165\/00044011-200323010-00008","article-title":"Use of quetiapine to manage patients who experienced adverse effects with clozapine","volume":"23","author":"Reinstein","year":"2003","journal-title":"Clin Drug Investig"},{"issue":"1","key":"10.1016\/j.encep.2022.03.013_bib0465","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1055\/s-2005-837771","article-title":"Reduction of side effects by combining clozapine with amisulpride: case report and short review of clozapine-induced hypersalivation-a case report","volume":"38","author":"Croissant","year":"2005","journal-title":"Pharmacopsychiatry"},{"issue":"3","key":"10.1016\/j.encep.2022.03.013_bib0460","first-page":"233","article-title":"Quetiapine-induced hypersalivation","volume":"9","author":"Allen","year":"2007","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"10.1016\/j.encep.2022.03.013_bib0485","series-title":"Clozapine adverse effects. The Maudsley prescribing guidelines in psychiatry, 13th ed.","first-page":"175","author":"Taylor","year":"2018"},{"issue":"2","key":"10.1016\/j.encep.2022.03.013_bib0490","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/YIC.0000000000000251","article-title":"Hyoscine for clozapine -induced hypersalivation: a double-blind, randomized, placebo-controlled cross-over trial","volume":"34","author":"Segev","year":"2019","journal-title":"Int Clin Psychopharmacol"},{"issue":"1","key":"10.1016\/j.encep.2022.03.013_bib0495","doi-asserted-by":"crossref","first-page":"109","DOI":"10.9758\/cpn.2015.13.1.109","article-title":"Effect of Scopolamine Butylbromide on Clozapine-induced Hypersalivation in Schizophrenic Patients: A Case Series","volume":"13","author":"Takeuchi","year":"2015","journal-title":"Clin Psychopharmacol Neurosci"},{"issue":"3","key":"10.1016\/j.encep.2022.03.013_bib0500","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1176\/appi.ps.55.3.318","article-title":"Scopolamine patch for clozapine-induced sialorrhea","volume":"55","author":"Gaftanyuk","year":"2004","journal-title":"Psychiatr Serv"},{"key":"10.1016\/j.encep.2022.03.013_bib0505","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1192\/pb.25.7.277-c","article-title":"Hyoscine patches in clozapine-induced hypersalivation","volume":"7","author":"McKane","year":"2001","journal-title":"Psychiatric Bulletin 25"},{"issue":"4","key":"10.1016\/j.encep.2022.03.013_bib0515","doi-asserted-by":"crossref","DOI":"10.1111\/appy.12269","article-title":"Effectiveness of the repeated administration of scopolamine ointment on clozapine-induced hypersalivation in patients with treatment-resistant schizophrenia: A preliminary study","volume":"9","author":"Takeuchi","year":"2017","journal-title":"Asia Pac Psychiatry"},{"issue":"1","key":"10.1016\/j.encep.2022.03.013_bib0510","doi-asserted-by":"crossref","DOI":"10.1097\/JCP.0000000000000613","article-title":"Scopolamine ointment for clozapine-associated sialorrhea: A case report","volume":"37","author":"Goto","year":"2017","journal-title":"J Clin Psychopharmacol"},{"issue":"11","key":"10.1016\/j.encep.2022.03.013_bib0520","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1002\/ccr3.2431","article-title":"The sublingual use of atropine in the treatment of clozapine-induced sialorrhea: A systematic review","volume":"7","author":"Van der Poorten","year":"2019","journal-title":"Clin Case Rep"},{"issue":"9","key":"10.1016\/j.encep.2022.03.013_bib0525","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1345\/aph.1E077","article-title":"Intraoral application of atropine sulfate ophthalmic solution for clozapine - induced sialorrhea","volume":"38","author":"Sharma","year":"2004","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.encep.2022.03.013_bib0530","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.schres.2016.10.039","article-title":"Sublingual atropine in the treatment of clozapine-induced sialorrhea","volume":"182","author":"Matos Santana","year":"2017","journal-title":"Schizophr Res"},{"issue":"6","key":"10.1016\/j.encep.2022.03.013_bib0535","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1080\/000486700285","article-title":"Use of atropine eye drops for clozapine induced hypersalivation","volume":"34","author":"Comley","year":"2000","journal-title":"Aust N Z J Psychiatry"},{"issue":"10","key":"10.1016\/j.encep.2022.03.013_bib0540","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1007\/s00213-020-05627-4","article-title":"The effect of sublingual atropine sulfate on clozapine-induced hypersalivation: a multicentre, randomised placebo-controlled trial","volume":"237","author":"Mubaslat","year":"2020","journal-title":"Psychopharmacology (Berl)"},{"issue":"4","key":"10.1016\/j.encep.2022.03.013_bib0545","first-page":"236","article-title":"Sublingual atropine for the treatment of severe and hyoscine-resistant clozapine-induced sialorrhea","volume":"16","author":"Mustafa","year":"2013","journal-title":"African J Psychiatry"},{"issue":"3","key":"10.1016\/j.encep.2022.03.013_bib0550","first-page":"250","article-title":"Clozapine and sialorrhea: a new intervention for this bothersome and potentially dangerous side effect","volume":"24","author":"Antonello","year":"1999","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.encep.2022.03.013_bib0555","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.schres.2016.12.028","article-title":"Potential problems surrounding the use of sublingually administered ophthalmic atropine for sialorrhea","volume":"185","author":"Leung","year":"2017","journal-title":"Schizophr Res"},{"key":"10.1016\/j.encep.2022.03.013_bib0560","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0031-6989(88)80839-7","article-title":"A comparative study of behavioural and autonomic effects of atropine and Atropa belladonna","volume":"20\u00a0Suppl 5","author":"Mazzanti","year":"1988","journal-title":"Pharmacol Res Commun"},{"key":"10.1016\/j.encep.2022.03.013_bib0565","article-title":"Hypersialorrh\u00e9e li\u00e9e \u00e0 l\u2019\u00e2ge - Stomatologiste, attach\u00e9 \u00e0 la clinique de stomatologie et chirurgie maxillaire faciale de l\u2019h\u00f4pital Salp\u00eatri\u00e8re de Paris","volume":"124-17","author":"Simone Imbert","year":"2002","journal-title":"Le concours m\u00e9dical, consultations"},{"issue":"1","key":"10.1016\/j.encep.2022.03.013_bib0595","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00004850-200015010-00008","article-title":"Potential use of ipatropium bromide for the treatment of clozapine -induced hypersalivation: a preliminary report","volume":"15","author":"Calderon","year":"2000","journal-title":"Int Clin Psychopharmacol"},{"issue":"3","key":"10.1016\/j.encep.2022.03.013_bib0600","first-page":"253","article-title":"Clozapine and sialorrhea: update","volume":"26","author":"Tessier","year":"2001","journal-title":"J Psychiatry Neurosci"},{"issue":"1","key":"10.1016\/j.encep.2022.03.013_bib0605","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/01.jcp.0000106228.36344.2e","article-title":"Clozapine-induced sialorrhea treated with sublingual ipratropium spray: a case series","volume":"24","author":"Freudenreich","year":"2004","journal-title":"J Clin Psychopharmacol"},{"issue":"8","key":"10.1016\/j.encep.2022.03.013_bib0610","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.4088\/JCP.08m04495","article-title":"Treatment of clozapine-induced hypersalivation with ipratropium bromide: a randomized, double-blind, placebo-controlled crossover study","volume":"70","author":"Sockalingam","year":"2009","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.encep.2022.03.013_bib0615","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/00004850-199707000-00005","article-title":"Trihexyphenidyl treatment of clozapine-induced hypersalivation","volume":"12","author":"Spivak","year":"1997","journal-title":"Int Clin Psycho-pharmacol"},{"issue":"4","key":"10.1016\/j.encep.2022.03.013_bib0620","first-page":"73","article-title":"Complete resolution of clozapine-induced sialorrhea with low dose trihexyphenidyl","volume":"43","author":"Praharaj","year":"2010","journal-title":"Psychopharmacol Bull"},{"issue":"10","key":"10.1016\/j.encep.2022.03.013_bib0625","doi-asserted-by":"crossref","first-page":"470","DOI":"10.4103\/0019-5359.57642","article-title":"Trihexyphenidyl (benzhexol) in clozapine-induced nocturnal enuresis and sialorrhea","volume":"63","author":"Aggarwal","year":"2009","journal-title":"Indian J Med Sci"},{"issue":"2","key":"10.1016\/j.encep.2022.03.013_bib0630","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.pnpbp.2008.12.016","article-title":"Aripiprazole-induced sialorrhea","volume":"33","author":"Praharaj","year":"2009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"2","key":"10.1016\/j.encep.2022.03.013_bib0635","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2165\/00044011-199917020-00003","article-title":"Comparative efficacy and tolerability of benzatropine and terazosin in the treatment of hypersalivation secondary to clozapine","volume":"17","author":"Reinstein","year":"1999","journal-title":"Clinical drug investigation"},{"issue":"3","key":"10.1016\/j.encep.2022.03.013_bib0640","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1176\/ajp.153.3.445a","article-title":"Treatment of clozapine-induced parotid gland swelling","volume":"153","author":"Brodkin","year":"1996","journal-title":"Am J Psychiatry"},{"issue":"15","key":"10.1016\/j.encep.2022.03.013_bib0570","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.2146\/ajhp130636","article-title":"Glycopyrrolate for treatment of clozapine-induced sialorrhea in adults","volume":"71","author":"Blissit","year":"2014","journal-title":"Am J Health Syst Pharm"},{"issue":"1","key":"10.1016\/j.encep.2022.03.013_bib0575","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1089\/cap.2007.0037","article-title":"Glycopyrrolate for treatment of clozapine-induced sialorrhea in three adolescents","volume":"18","author":"Robb","year":"2008","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"1-3","key":"10.1016\/j.encep.2022.03.013_bib0580","doi-asserted-by":"crossref","DOI":"10.1016\/j.schres.2010.02.1060","article-title":"Comparison of the efficacy and impact on cognition of glycopyrrolate and biperiden for clozapine-induced sialorrhea in schizophrenic patients: a randomized, double-blind, crossover study","volume":"119","author":"Liang","year":"2010","journal-title":"Schizophr Res"},{"issue":"3","key":"10.1016\/j.encep.2022.03.013_bib0480","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/JCP.0000000000000102","article-title":"Low-dose glycopyrrolate for clozapine-associated sialorrhea","volume":"34","author":"Praharaj","year":"2014","journal-title":"J Clin Psychopharmacol"},{"issue":"2","key":"10.1016\/j.encep.2022.03.013_bib0585","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/JCP.0000000000000657","article-title":"The effect of glycopyrrolate on nocturnal sialorrhea in patients using clozapine: a randomized, crossover, double-blind, placebo-controlled trial","volume":"37","author":"Man","year":"2017","journal-title":"J Clin Psychopharmacol"},{"issue":"7","key":"10.1016\/j.encep.2022.03.013_bib0590","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/j.pnpbp.2007.06.013","article-title":"Glycopyrrolate for clozapine-induced sialorrhea","volume":"31","author":"Duggal","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"9","key":"10.1016\/j.encep.2022.03.013_bib0690","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1345\/aph.1Q270","article-title":"Immediate-release oxybutynin for the treatment of clozapine-induced sialorrhea","volume":"45","author":"Leung","year":"2011","journal-title":"Ann Pharmacother"},{"issue":"3","key":"10.1016\/j.encep.2022.03.013_bib0695","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1089\/cap.2011.0097","article-title":"Diphenhydramine use in the treatment of risperidone-induced sialorrhea","volume":"22","author":"Usta","year":"2012","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"8981","key":"10.1016\/j.encep.2022.03.013_bib0665","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/S0140-6736(95)91713-6","article-title":"Pirenzepine for clozapine-induced hypersalivation [letter]","volume":"346","author":"Fritze","year":"1995","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.encep.2022.03.013_bib0670","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1055\/s-2004-815523","article-title":"Reduction of clozapine-induced hypersalivation by pirenzepine is safe","volume":"37","author":"Schneider","year":"2004","journal-title":"Pharmacopsychiatry"},{"issue":"6","key":"10.1016\/j.encep.2022.03.013_bib0675","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/00004714-200112000-00012","article-title":"Therapeutic effect of pirenzepine for clozapine-induced hypersalivation: a randomized, double-blind, placebo-controlled, cross-over study","volume":"21","author":"Bai","year":"2001","journal-title":"J Clin Psychopharmacol"},{"issue":"8","key":"10.1016\/j.encep.2022.03.013_bib0680","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1176\/appi.ajp.158.8.1329-a","article-title":"Biperiden for excessive sweating from clozapine","volume":"158","author":"Richardson","year":"2001","journal-title":"Am J Psychiatry"},{"issue":"1-3","key":"10.1016\/j.encep.2022.03.013_bib0685","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.schres.2007.03.006","article-title":"Risperidone-induced sialorrhea responsive to biperiden treatment","volume":"93","author":"Panagiotidis","year":"2007","journal-title":"Schizophr Res"},{"issue":"4","key":"10.1016\/j.encep.2022.03.013_bib0705","first-page":"431","article-title":"Tropicamide ophthalmic solution reduces clozapine -induced sialorrhea: a case report","volume":"27","author":"Kilic","year":"2017","journal-title":"Psychiatry Behav Sci"},{"issue":"3","key":"10.1016\/j.encep.2022.03.013_bib0700","first-page":"CD005579","article-title":"Pharmacological interventions for clozapine -induced hypersalivation","author":"Syed","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.encep.2022.03.013_bib0645","first-page":"159","article-title":"Amitriptyline in clozapine-induced sialorrhea","author":"Copp","year":"1991","journal-title":"Br J Psychiatry"},{"issue":"3","key":"10.1016\/j.encep.2022.03.013_bib0650","doi-asserted-by":"crossref","first-page":"262","DOI":"10.2174\/1574886311666160426130252","article-title":"Very low dose amitriptyline for clozapine-associated sialorrhea","volume":"11","author":"Sinha","year":"2016","journal-title":"Curr Drug Saf"},{"issue":"1","key":"10.1016\/j.encep.2022.03.013_bib0655","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1365-2125.2006.02748.x","article-title":"Amitriptyline for clozapine-induced nocturnal enuresis and sialorrhoea","volume":"63","author":"Praharaj","year":"2007","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.encep.2022.03.013_bib0660","first-page":"176","article-title":"Aripiprazole-induced sialorrhea responsive to amitriptyline treatment","volume":"7","author":"Gundogmus","year":"2017","journal-title":"Psychiatry Behav Sci"},{"key":"10.1016\/j.encep.2022.03.013_bib0710","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00004714-199202000-00026","article-title":"Clonidine treatment of clozapine-induced hyper- salivation","volume":"12","author":"Grabowski","year":"1992","journal-title":"J Clin Psychopharmacol"},{"issue":"4","key":"10.1016\/j.encep.2022.03.013_bib0715","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1177\/0269881105053311","article-title":"Is clonidine useful for treatment of clozapine-induced sialorrhea?","volume":"19","author":"Praharaj","year":"2005","journal-title":"J Psychopharmacol"},{"issue":"1","key":"10.1016\/j.encep.2022.03.013_bib0720","doi-asserted-by":"crossref","first-page":"34","DOI":"10.9740\/mhc.2020.01.034","article-title":"Thrombocytopenia associated with clonidine in a case of clozapine-induced sialorrhea","volume":"10","author":"Leung","year":"2020","journal-title":"Ment Health Clin"},{"issue":"3","key":"10.1016\/j.encep.2022.03.013_bib0725","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1192\/bjp.167.3.412a","article-title":"Clozapine-induced hypersalivation and the alpha 2\u00a0adrenoceptor [letter]","volume":"167","author":"Corrigan","year":"1995","journal-title":"Br J Psychiatry"},{"issue":"6","key":"10.1016\/j.encep.2022.03.013_bib0730","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/01.jcp.0000145348.06783.1d","article-title":"Guanfacine treatment of clozapine-induced sialorrhea","volume":"24","author":"Webber","year":"2004","journal-title":"J Clin Psychopharmacol"},{"issue":"3","key":"10.1016\/j.encep.2022.03.013_bib0735","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/WNF.0b013e31818f1111","article-title":"Moclobemide treatment of clozapine -induced hypersalivation: pilot open study","volume":"32","author":"Kreinin","year":"2009","journal-title":"Clin Neuropharmacol"},{"issue":"8","key":"10.1016\/j.encep.2022.03.013_bib0740","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.pnpbp.2009.09.014","article-title":"Clozapine-induced sialorrhea alleviated by bupropion--a case report","volume":"33","author":"Stern","year":"2009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"4","key":"10.1016\/j.encep.2022.03.013_bib0750","doi-asserted-by":"crossref","first-page":"446","DOI":"10.4103\/0253-7176.168592","article-title":"Low-dose amisulpride for debilitating clozapine-induced sialorrhea: Case series and review of literature","volume":"37","author":"Kulkarni","year":"2015","journal-title":"Indian J Psychol Med"},{"issue":"3","key":"10.1016\/j.encep.2022.03.013_bib0755","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/JCP.0000000000000493","article-title":"Double-blind, randomized, placebo-controlled trial of metoclopramide for hypersalivation associated with clozapine","volume":"36","author":"Kreinin","year":"2016","journal-title":"J Clin Psychopharmacol"},{"issue":"4","key":"10.1016\/j.encep.2022.03.013_bib0760","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1136\/eb-2016-102445","article-title":"Metoclopramide may be effective for clozapine-induced hypersalivation","volume":"19","author":"Hallahan","year":"2016","journal-title":"Evid Based Ment Health"},{"issue":"2","key":"10.1016\/j.encep.2022.03.013_bib0775","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/JCP.0b013e318199f264","article-title":"Amisulpride treatment for clozapine-induced sialorrhea","volume":"29","author":"Praharaj","year":"2009","journal-title":"J Clin Psychopharmacol"},{"issue":"3","key":"10.1016\/j.encep.2022.03.013_bib0780","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1097\/MJT.0b013e3181c84bbd","article-title":"Amisulpride improved debilitating clozapine-induced sialorrhea","volume":"18","author":"Praharaj","year":"2011","journal-title":"Am J Ther"},{"issue":"2","key":"10.1016\/j.encep.2022.03.013_bib0785","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/01.yic.0000188216.92408.69","article-title":"Amisulpride treatment of clozapine-induced hypersalivation in schizophrenia patients: a randomized, double-blind, placebo-controlled cross-over study","volume":"21","author":"Kreinin","year":"2006","journal-title":"Int Clin Psychopharmacol"},{"issue":"8","key":"10.1016\/j.encep.2022.03.013_bib0435","doi-asserted-by":"crossref","first-page":"620","DOI":"10.3109\/15622975.2010.527370","article-title":"Amisulpride versus moclobemide in treatment of clozapine-induced hypersalivation","volume":"12","author":"Kreinin","year":"2011","journal-title":"World J Biol Psychiatry"},{"key":"10.1016\/j.encep.2022.03.013_bib0745","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1192\/bjp.171.6.569","article-title":"Sulpiride augmentation in people with schizophrenia partially responsive to clozapine. A double-blind, placebo-controlled study","volume":"171","author":"Shiloh","year":"1997","journal-title":"Br J Psychiatry"},{"issue":"1","key":"10.1016\/j.encep.2022.03.013_bib0765","first-page":"61","article-title":"Sulpiride addition for the treatment of clozapine-induced hypersalivation: preliminary study","volume":"42","author":"Kreinin","year":"2005","journal-title":"Isr J Psychiatry Relat Sci"},{"issue":"4","key":"10.1016\/j.encep.2022.03.013_bib0790","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/YIC.0000000000000297","article-title":"Effect of N-acetylcysteine on clozapine-induced sialorrhea in schizophrenic patients: a case series","volume":"35","author":"Uzun","year":"2020","journal-title":"Int Clin Psychopharmacol"},{"issue":"1-2","key":"10.1016\/j.encep.2022.03.013_bib0795","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00213-004-1803-0","article-title":"Botulinum toxin as an effective treatment of clozapine- induced hypersalivation","volume":"173","author":"Kahl","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"10.1016\/j.encep.2022.03.013_bib0800","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00213-017-4795-2","article-title":"Botulinum toxin: a novel therapy for clozapine-induced sialorrhoea","volume":"235","author":"Verma","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.encep.2022.03.013_bib0810","first-page":"593","article-title":"Early Use of Botulinum Neurotoxin Treatment for Clozapine-induced Sialorrhea","author":"Moss","year":"2021","journal-title":"J Acad Consult Liaison Psychiatry"},{"issue":"4","key":"10.1016\/j.encep.2022.03.013_bib0805","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00213-009-1689-y","article-title":"Botulinum toxin B as an effective and safe treatment for neuroleptic-induced sialorrhea","volume":"207","author":"Steinlechner","year":"2010","journal-title":"Psychopharmacology (Berl)"},{"issue":"4","key":"10.1016\/j.encep.2022.03.013_bib0770","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/hup.2408","article-title":"Polymorphism in alpha 2A adrenergic receptor gene is associated with sialorrhea in schizophrenia patients on clozapine treatment","volume":"29","author":"Solismaa","year":"2014","journal-title":"Hum Psychopharmacol"},{"issue":"5","key":"10.1016\/j.encep.2022.03.013_bib0815","first-page":"356","article-title":"Mobile devices and apps for health care professionals: uses and benefits","volume":"39","author":"Ventola","year":"2014","journal-title":"P & T: a peer-reviewed journal for formulary management"}],"container-title":["L'Enc\u00e9phale"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013700622001270?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013700622001270?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T17:42:30Z","timestamp":1757958150000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0013700622001270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":82,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S0013700622001270"],"URL":"https:\/\/doi.org\/10.1016\/j.encep.2022.03.013","relation":{},"ISSN":["0013-7006"],"issn-type":[{"value":"0013-7006","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prise en charge de l\u2019hypersialorrh\u00e9e iatrog\u00e8ne\u00a0: revue de la litt\u00e9rature et recommandations pratiques","name":"articletitle","label":"Article Title"},{"value":"L'Enc\u00e9phale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.encep.2022.03.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 L'Enc\u00e9phale, Paris.","name":"copyright","label":"Copyright"}]}}